2025 Agenda

Wednesday, October 8, 2025

Location: CURE.
345 Park Avenue SOUTH, New York, NY 10010
3:30Pm Registration Opens
4:00pm Welcoming Remarks
Cure. Rooftop

  • Clinton T. Rubin, PhD, Director, Center for Biotechnology
  • Seema Kumar, MS, CEO, Cure.

Kick Off Plenary Session: Sustaining U.S. Global Primacy in Life Sciences Partnerships

Moderator: John Prufeta, General Partner, Medical Excellence Capital, LLC

  • Parastoo Khoshakhlagh, PhD, CEO & Co-Founder, GC Therapeutics
  • Kim Raineri, MBA, Chief Technology Officer, Aspen Neuroscience 
  • Arda Ural, PhD, Americas Life Sciences Leader, Ernst & Young LLP                          
5:30pm VIP Reception 

Thursday, October 9, 2025

Location: Apella by Alexandria
450 East 29th Street, 2nd Floor, New York, NY 10016
8:00am  Registration Opens
9:00am Welcoming Remarks & Opening Plenary Session: The Leadership Imperative: Guiding Therapies, Diagnostics, and Biomedicine from Vision to Impact
Suite 200Moderator: Tamar R. Gubins, Partner, Fox Rothschild LLP

  • Stan Abel, MBA, CEO, ProJenX
  • Laurence Blumberg, MD, Biotechnology Executive
  • Cristina Larkin, CEO, Mobius Care 
  • Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures
9:45am  Emerging Company Showcase – Session 1
Suite 203 

  • 9:45 AM: XM Therapeutics, Inc.
  • 10:00 AM: EyeVision Pharma
  • 10:15 AM: ProViZigen LLC
9:45am

Emerging Company Showcase – Session 2
Suite 207

  • 9:45 AM: D2B3 Bio 
  • 10:00 AM: Lahara Bio
  • 10:15 AM: Centron Bio
10:45am Venture Spotlight: Paradigm-Shifting Medicine at the Industry’s Inflection Point
Suite 200Moderator: Seema Kumar, CEO, CURE.

  • Kim Raineri, Chief Technology Officer, Aspen Neuroscience
  • James R. Tonra, PhD, President & CSO, SEED Therapeutics, Inc
  • Michael Torres, PhD, CEO & Co-Founder, CrossBridge Bio
 11:40am  Emerging Company Showcase – Session 3
Suite 203 

  • 11:40 AM: Sidereal Therapeutics
  • 11:55 AM: Ancilia Biosciences Inc.
  • 12:10 PM: Calder Biosciences
 11:40am Emerging Company Showcase – Session 4
Suite 207

  • 11:40 AM: CrossBridge Bio
  • 11:55 AM: Seed Therapeutics 
  • 12:10 PM: Aspen Neuroscience
12:45pm Luncheon Plenary: The Next Frontier In Clinical Development: China as Biotech’s Global Accelerator
Suite 200Moderator: Michael Baran, PhD, MBA, Partner, Pfizer Ventures

  • Artavazd Arumov, PhD, Principal, Qiming Venture Partners USA
  • Ting Feng, PhD, Partner, Sirona Capital
  • Aamir Mecklai, MBA, Managing Director, Healthcare Investment Banking, Bank of America
  • Su Zhang, PharmD, MBA, CEO & acting CBO, CoDevCo
 1:45pm Emerging Company Showcase – Session 5
Suite 203 

  • 1:45 PM: Telos Biotech, Inc.
  • 2:00 PM: Raadysan Biotech, Inc.
  • 2:15 PM: Piston Bio LLC
1:45pm Emerging Company Showcase – Session 6
Suite 207

  • 1:45 PM: UbiquiTx
  • 2:00 PM: GeneVentiv Therapeutics
  • 2:15 PM: Nephrogen
2:30pm Plenary: From Lifespan to Healthspan: Investing in a New Healthcare Paradigm
Suite 200Moderator: Keith Comito, MS, CEO & President, Lifespan Research Institute

  • Matt Kaeberlein, PhD, CEO Optispan, Advisor, Circulate Health
  • Fiona Miller, Managing Partner, quadraScope
  • Reason, MS, CEO, Repair Biotechnologies 
  • Nina Tandon, PhD, MBA, CEO & Co-Founder, EpiBione, Inc. 
 3:30pm Emerging Company Showcase – Session 7
Suite 203

  • 3:30 PM: Vivacelle Bio
  • 3:45 PM: Foli Bio
  • 4:00 PM: Bioio, Inc.
3:30pm Emerging Company Showcase – Session 8
Suite 207

  • 3:30 PM: Onselex Pharmaceuticals
  • 3:45 PM: Valenyx Therapeutics
  • 4:00 PM: Frezent Biological Solutions Inc.
4:15pm Closing Plenary Session: Investor Round Table: Resilience and Innovation in Life Sciences Amid Macro Shifts
Suite 200 Moderator: Kim Kamdar, PhD, Managing Partner, Medical Excellence Capital, LLCPanelists:

  • Megan Blewett, PhD, Principal, Scion Life Sciences
  • Sonia Gulati, PhD, Partner, Global BioAccess Fund
  • Eric Heil, MBA, Managing Partner, Medical Excellence Capital, LLC 
  • Jonathan Mandelbaum, PhD, Vice President, Orbimed
5:15pm Networking Reception